Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Leukapheresis Device Market Size Outlook: How Quickly Will Revenue Expand Through 2030?#_x000D_
The size of the leukapheresis device market has demonstrated robust growth recently. This market is forecast to expand from $0.7 billion in 2025 to $0.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion can be ascribed to several factors, including the increasing prevalence of leukemia and autoimmune disorders, the wider adoption of stem cell therapies, significant advancements in blood cell separation technology, a rise in clinical research activities, and the expansion of hospital-based apheresis services._x000D_
_x000D_
The leukapheresis device market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $1.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. Key factors driving this growth during the projected period include the increasing demand for portable leukapheresis systems, the incorporation of AI and automation into devices, the broadening scope of biopharmaceutical research, new regulatory approvals for sophisticated apheresis technologies, and increased investments in precision medicine. Prominent trends expected over the forecast horizon encompass individualized leukapheresis therapies, less invasive apheresis methods, portable and point-of-care leukapheresis equipment, the incorporation of real-time monitoring systems, and improvements in automation and operational efficiency._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Leukapheresis Device Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The increasing occurrence of blood-related conditions is anticipated to drive the expansion of the leukapheresis device market in the future. These conditions impact the composition or operation of blood cells, leading to issues with oxygen transport, immune system function, or blood coagulation. The growing number of blood-related disorders is mainly due to an older demographic, as elderly individuals are more prone to ailments such as anemia, leukemia, and various hematological conditions. Leukapheresis equipment aids in managing these illnesses by precisely removing surplus or abnormal white blood cells from circulation, thereby helping to ease symptoms and lessen complications in diseases like leukemia and autoimmune conditions. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians received a diagnosis of blood cancer, including leukemia, lymphoma, and myeloma, with almost 43% incurring substantial out-of-pocket treatment expenses and 42% needing over three months away from work, underscoring both the increased frequency and the financial strain on patients and their relatives compared to prior years. Consequently, the escalating incidence of blood-related disorders is fueling the expansion of the leukapheresis device market._x000D_
_x000D_
#Leukapheresis Device Market Segment Analysis And Revenue Potential#_x000D_
The leukapheresis device market covered in this report is segmented – _x000D_
_x000D_
1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices_x000D_
2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters_x000D_
3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers_x000D_
_x000D_
Subsegments:_x000D_
1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices_x000D_
2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems_x000D_
3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems_x000D_
4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices_x000D_
5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators_x000D_
6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags_x000D_
7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems_x000D_
_x000D_
#Leukapheresis Device Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Major companies in the leukapheresis device market are concentrating on funneling capital into regional production capabilities to boost local access to high-quality therapeutic devices and support national healthcare aims. Investments in regional manufacturing aid in establishing efficient and flexible supply chains, which ensure on-time delivery, lessen dependence on imports, and enhance the affordability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology company, partnered with Terumo Medical Products (Hangzhou) Co., Ltd., a China-based medical technology subsidiary company, to inaugurate localized production in Hangzhou, China. This strategic initiative involves the domestic manufacturing of key leukapheresis products, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both extensively employed in China for therapeutic apheresis, stem cell collection, and blood component separation._x000D_
_x000D_
#Leukapheresis Device Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation _x000D_
_x000D_
#View The Full Leukapheresis Device Market Report:#_x000D_
_x000D_
#Leukapheresis Device Market Leading Geography: Which Region Contributes The Most Revenue?#_x000D_
North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model